Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Gross Profit
Dexcom Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Gross Profit
$2.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
37%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$9.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is Dexcom Inc's Gross Profit?
Gross Profit
2.3B
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Gross Profit amounts to 2.3B USD.
What is Dexcom Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
37%
Over the last year, the Gross Profit growth was 22%. The average annual Gross Profit growth rates for Dexcom Inc have been 21% over the past three years , 28% over the past five years , and 37% over the past ten years .